Drug Profile
Menotropin - Ferring Pharmaceuticals
Alternative Names: HMG; HP-hMG; Human menopausal gonadotrophin; Menogon; Menopur; Menopur® Pen; Menotrophin; Menotropins; Merapur; Meropur; RepronexLatest Information Update: 29 Aug 2022
Price :
$50
*
At a glance
- Originator Ferring Pharmaceuticals
- Class Infertility therapies; Menotropins
- Mechanism of Action Ovarian follicle stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Female infertility; Polycystic ovary syndrome
Most Recent Events
- 15 Aug 2022 Ferring Pharmaceuticals completes a phase I trial in Female infertility in China (SC) (NCT04902131)
- 09 Dec 2021 Phase-III clinical trials in Female infertility in Japan (SC), prior to December 2021 (Ferring Pharmaceuticals pipeline, December 2021)
- 02 Nov 2021 Ferring Pharmaceuticals initiates a phase I trial for Female infertility in China (SC) (NCT04902131)